Engineered immune cells take aim at rare blistering disease
Disease control
Recruiting now
This study tests two types of engineered immune cells (CAR T-cells) in 40 adults with active pemphigus vulgaris, a painful blistering skin condition. The goal is to see if these cells can safely control the disease by targeting faulty immune cells. Participants receive a one-time…
Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated May 11, 2026 20:51 UTC